CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cellsGianluca Storci, Francesca Bonifazi, Enrica Tomassini et al.|Journal of Clinical Investigation|2024Cited by 28
The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemiaEnrico Maffini, Francesca Bonifazi, Margherita Ursi et al.|Frontiers in Oncology|2022Cited by 8
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcomeSerena De Matteis, Francesca Bonifazi, Laura Del Coco et al.|Haematologica|2024Cited by 3
Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantationEnrico Maffini, Francesca Bonifazi, Moreno Festuccia et al.|Current Opinion in Hematology|2022Cited by 1
The Impact of the Absolute Lymphocyte Count before Anti-T-Lymphocyte Globulin (ATLG) Administration on Transplant Outcomes in Matched Unrelated Peripheral Blood Stem Cell Allogeneic Stem Cell TransplantationRadwan Massoud, Francesca Bonifazi, Margherita Ursi et al.|Blood|2024Cited by 0